At close: December 11 at 4:00:02 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
419,146.0000
425,174.0000
406,365.0000
386,905.0000
362,048.0000
Cost of Revenue
134,060.0000
135,114.0000
129,998.0000
120,863.0000
112,146.0000
Gross Profit
285,086.0000
290,060.0000
276,367.0000
266,042.0000
249,902.0000
Operating Expense
368,570.0000
389,368.0000
375,203.0000
356,976.0000
312,754.0000
Operating Income
-83,484.0000
-99,308.0000
-98,836.0000
-90,934.0000
-62,852.0000
Net Non Operating Interest Income Expense
-9,157.0000
6,152.0000
-2,411.0000
-19,078.0000
-18,850.0000
Other Income Expense
17,678.0000
-4,703.0000
105,511.0000
-20,814.0000
-495.0000
Pretax Income
-74,963.0000
-97,859.0000
4,264.0000
-130,826.0000
-82,197.0000
Tax Provision
-5,654.0000
-5,646.0000
1,263.0000
534.0000
868.0000
Net Income Common Stockholders
-69,309.0000
-92,213.0000
3,001.0000
-131,360.0000
-83,065.0000
Diluted NI Available to Com Stockholders
-69,309.0000
-92,213.0000
3,001.0000
-131,360.0000
-83,065.0000
Basic EPS
-1.87
-2.56
0.08
-3.77
-2.47
Diluted EPS
-1.87
-2.56
0.08
-3.77
-2.47
Basic Average Shares
36,752.7350
35,981.4310
35,317.6440
34,823.2580
33,677.6410
Diluted Average Shares
36,752.7350
35,981.4310
35,525.2550
34,823.2580
33,677.6410
Total Operating Income as Reported
-86,608.0000
-99,308.0000
6,164.0000
-110,934.0000
-62,852.0000
Total Expenses
502,630.0000
524,482.0000
505,201.0000
477,839.0000
424,900.0000
Net Income from Continuing & Discontinued Operation
-69,309.0000
-92,213.0000
3,001.0000
-131,360.0000
-83,065.0000
Normalized Income
-87,117.2607
-88,330.6690
-70,919.0000
-116,760.0000
-83,065.0000
Interest Income
14,269.0000
14,166.0000
4,021.0000
671.0000
2,956.0000
Interest Expense
23,426.0000
8,014.0000
6,432.0000
19,749.0000
21,806.0000
Net Interest Income
-9,157.0000
6,152.0000
-2,411.0000
-19,078.0000
-18,850.0000
EBIT
-51,537.0000
-89,845.0000
10,696.0000
-111,077.0000
-60,391.0000
EBITDA
-37,457.0000
-78,310.0000
21,023.0000
-102,399.0000
-52,205.0000
Reconciled Cost of Revenue
122,437.0000
123,825.0000
119,671.0000
112,185.0000
112,146.0000
Reconciled Depreciation
14,080.0000
11,535.0000
10,327.0000
8,678.0000
8,186.0000
Net Income from Continuing Operation Net Minority Interest
-69,309.0000
-92,213.0000
3,001.0000
-131,360.0000
-83,065.0000
Total Unusual Items Excluding Goodwill
19,261.0000
-4,117.0000
105,000.0000
-20,000.0000
--
Total Unusual Items
19,261.0000
-4,117.0000
105,000.0000
-20,000.0000
--
Normalized EBITDA
-56,718.0000
-74,193.0000
-83,977.0000
-82,399.0000
-52,205.0000
Tax Rate for Calcs
0.0001
0.0001
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
1,452.7393
-234.6690
31,080.0000
-5,400.0000
--
12/31/2020 - 11/6/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PEN Penumbra, Inc.
253.66
+4.70%
SIBN SI-BONE, Inc.
13.83
-2.61%
SGHT Sight Sciences, Inc.
3.9000
-0.26%
IRTC iRhythm Technologies, Inc.
89.93
+3.49%
LIVN LivaNova PLC
51.49
+2.90%
KIDS OrthoPediatrics Corp.
23.03
+0.22%
INSP Inspire Medical Systems, Inc.
192.77
+1.77%
NARI Inari Medical, Inc.
58.21
+5.74%
NPCE NeuroPace, Inc.
11.08
-3.74%
CUTR Cutera, Inc.
0.3600
-6.64%